Clinical, Pharmacodynamic, and Pharmacokinetic Evaluation of BNC105P: A Phase I Trial of a Novel Vascular Disrupting Agent and Inhibitor of Cancer Cell Proliferation
2011 ◽
Vol 17
(15)
◽
pp. 5152-5160
◽
2010 ◽
Vol 103
(5)
◽
pp. 597-606
◽
2012 ◽
Vol 18
(5)
◽
pp. 1415-1425
◽
Keyword(s):
2017 ◽
Vol 14
(02)
◽
pp. A1-A53